- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA Mutations and Breast Cancer Prevention
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 12, Pages 524
Publisher
MDPI AG
Online
2018-12-20
DOI
10.3390/cancers10120524
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complications in Postmastectomy Breast Reconstruction
- (2018) Edwin G. Wilkins et al. ANNALS OF SURGERY
- Hospital Variations in Clinical Complications and Patient-reported Outcomes at 2 Years After Immediate Breast Reconstruction
- (2018) Nicholas L. Berlin et al. ANNALS OF SURGERY
- Personalized prevention in high risk individuals: Managing hormones and beyond
- (2018) D. Gareth Evans et al. BREAST
- Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
- (2018) Jacqueline Lammert et al. BREAST CANCER RESEARCH AND TREATMENT
- The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer
- (2018) K.A. Metcalfe et al. CLINICAL GENETICS
- Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
- (2018) Joanne Kotsopoulos et al. GYNECOLOGIC ONCOLOGY
- The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers
- (2018) Kwang-Pil Ko et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers
- (2018) Shana J Kim et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations
- (2018) James W. Jakub et al. JAMA Surgery
- Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
- (2018) Joanne Kotsopoulos et al. JAMA Oncology
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers
- (2018) Yael Laitman et al. CANCER
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preventive therapy for cancer
- (2017) Jack Cuzick LANCET ONCOLOGY
- The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients
- (2016) T. Huzarski et al. BREAST CANCER RESEARCH AND TREATMENT
- Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
- (2016) Jon G Jonasson et al. BRITISH JOURNAL OF CANCER
- RANKL/RANK control Brca1 mutation-driven mammary tumors
- (2016) Verena Sigl et al. CELL RESEARCH
- Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review
- (2016) X. Li et al. CLINICAL CANCER RESEARCH
- Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers
- (2016) Joanne Kotsopoulos et al. JNCI-Journal of the National Cancer Institute
- Role of the RANK/RANKL pathway in breast cancer
- (2016) Ludwig Kiesel et al. MATURITAS
- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
- (2016) Emma Nolan et al. NATURE MEDICINE
- The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
- (2016) Lynn C. Hartmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial
- (2016) Marion Kiechle et al. Trials
- Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
- (2016) Lovisa Odén et al. Oncotarget
- Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers
- (2016) Joanne Kotsopoulos et al. JNCI-Journal of the National Cancer Institute
- Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference?
- (2015) Kelly A. Metcalfe et al. ANNALS OF SURGICAL ONCOLOGY
- Active and passive smoking and risk of breast cancer: a meta-analysis
- (2015) Alina Macacu et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical management of women at high risk of breast cancer
- (2015) Melanie Wuttke et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study
- (2015) Yakir Segev et al. Familial Cancer
- The RANKL-RANK Story
- (2015) Vanja Nagy et al. GERONTOLOGY
- Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
- (2015) B. A. M. Heemskerk-Gerritsen et al. JNCI-Journal of the National Cancer Institute
- Tamoxifen and risk of contralateral breast cancer among women with inherited mutations in BRCA1 and BRCA2: a meta-analysis
- (2015) Lingyun Xu et al. Breast Cancer
- Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
- (2015) B. A. M. Heemskerk-Gerritsen et al. JNCI-Journal of the National Cancer Institute
- Effect of Oophorectomy on Survival After Breast Cancer inBRCA1andBRCA2Mutation Carriers
- (2015) Kelly Metcalfe et al. JAMA Oncology
- Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone
- (2015) Rowan T. Chlebowski et al. JAMA Oncology
- Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
- (2015) Martin Widschwendter et al. EBioMedicine
- Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2014) Jacek Gronwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers
- (2014) Joanne Kotsopoulos et al. BREAST CANCER RESEARCH AND TREATMENT
- Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
- (2014) V Bagnardi et al. BRITISH JOURNAL OF CANCER
- Factors influencing ovulation and the risk of ovarian cancer inBRCA1andBRCA2mutation carriers
- (2014) Joanne Kotsopoulos et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
- (2014) Amy P.M. Finch et al. JOURNAL OF CLINICAL ONCOLOGY
- A prospective study of mastectomy patients with and without delayed breast reconstruction: Long-term psychosocial functioning in the breast cancer survivorship period
- (2014) Kelly A. Metcalfe et al. JOURNAL OF SURGICAL ONCOLOGY
- Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
- (2014) Tara M. Friebel et al. JNCI-Journal of the National Cancer Institute
- Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis
- (2013) B. A. M. Heemskerk-Gerritsen et al. ANNALS OF ONCOLOGY
- PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
- (2013) J.-m. Lee et al. ANNALS OF ONCOLOGY
- Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells
- (2013) H. J. Lee et al. DEVELOPMENT
- Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis
- (2013) Patricia G. Moorman et al. JOURNAL OF CLINICAL ONCOLOGY
- Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2013) Kelly-Anne Phillips et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
- (2013) Jack Cuzick et al. LANCET
- The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
- (2013) Martin Widschwendter et al. LANCET ONCOLOGY
- Progesterone Receptor and Stat5 Signaling Cross Talk Through RANKL in Mammary Epithelial Cells
- (2013) Alison E. Obr et al. MOLECULAR ENDOCRINOLOGY
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- (2012) N. Mavaddat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
- (2012) J. Kotsopoulos et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Denosumab: mechanism of action and clinical outcomes
- (2012) D. A. Hanley et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)
- (2011) Julie Lecarpentier et al. BREAST CANCER RESEARCH AND TREATMENT
- Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2011) Kelly Metcalfe et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast Cancer Risk in Relation to Alcohol Consumption and BRCA Gene Mutations - A Case-Only Study of Gene-Environment Interaction
- (2011) Jessica Dennis et al. Breast Journal
- Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- (2011) K Metcalfe et al. BRITISH JOURNAL OF CANCER
- Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk
- (2011) Wendy Y. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RANKL/RANK—beyond bones
- (2011) Reiko Hanada et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study
- (2011) J. Cuzick et al. JNCI-Journal of the National Cancer Institute
- Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers
- (2010) Jessica Dennis et al. BREAST
- Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
- (2010) Patricia G. Moorman et al. BREAST CANCER RESEARCH AND TREATMENT
- Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
- (2010) Kerryn W. Reding et al. BREAST CANCER RESEARCH AND TREATMENT
- Pathology of hereditary breast cancer
- (2010) Leonard Da Silva et al. MODERN PATHOLOGY
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
- (2010) Eva Gonzalez-Suarez et al. NATURE
- Control of mammary stem cell function by steroid hormone signalling
- (2010) Marie-Liesse Asselin-Labat et al. NATURE
- Progesterone induces adult mammary stem cell expansion
- (2010) Purna A. Joshi et al. NATURE
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- (2010) Daniel Schramek et al. NATURE
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
- (2009) T. R. Rebbeck et al. JNCI-Journal of the National Cancer Institute
- Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update
- (2008) Ophira Ginsburg et al. BREAST CANCER RESEARCH AND TREATMENT
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
- (2008) Kelly A. Metcalfe et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now